Stathmin-deficient mice develop fibrosis and show delayed recovery from ischemic-reperfusion injury

American Journal of Physiology - Renal Physiology

Volumn 290, Issue 6, 2006, Pages

  Zahedi, Kamyar ^a,d   Revelo, Monica P ^a   Barone, Sharon ^a   Wang, Zhaohui ^a   Tehrani, Kathy ^a   Citron, David P ^a   Bissler, John J ^a   Rabb, Hamid ^c   Soleimani, Manoocher ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Acute renal failure; Cell proliferation; Fibrosis; Renal function

Indexed keywords

BINDING PROTEIN; STATHMIN; TUBULIN;

ACUTE KIDNEY FAILURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; DNA REPAIR; ENZYME ACTIVITY; FIBROSIS; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY TUBULE CELL; MITOSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION; REPERFUSION INJURY; UPREGULATION; WILD TYPE;

EID: 33744799971     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00424.2005     Document Type: Article

References (47)

1. Alaiya AA, Franzen B, Fujioka K, Moberger B, Schedvins K, Silfversvard C, Linder S, and Auer G. Phenotypic analysis of ovarian carcinoma: polypeptide expression in benign, borderline and malignant tumors. Int J Cancer 73: 678-683, 1997.
2. Basile DP, Donohoe D, Roethe K, and Osborn JL. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am J Physiol Renal Physiol 281: F887-F899, 2001.
3. Bieche I, Lachkar S, Becette V, Cifuentes-Diaz C, Sobel A, Lidereau R, and Curmi PA. Overexpression of the stathmin gene in a subset of human breast cancer. Br J Cancer 78: 701-709, 1998.
4. Bonventre JV. Mechanisms of ischemic acute renal failure. Kidney Int 43: 1160-1178, 1993.
5. Brattsand G, Roos G, Marklund U, Ueda H, Landberg G, Nanberg E, Sideras P, and Gullberg M. Quantitative analysis of the expression and regulation of an activation-regulated phosphoprotein (oncoprotein 18) in normal and neoplastic cells. Leukemia 7: 569-579, 1993.
6. Bravo R, Frank R, Blundell PA, and Macdonald-Bravo H. Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature 326: 515-517, 1987.
7. Ferrari AC, Seuanez HN, Hanash SM, and Atweh GF. A gene that encodes for a leukemia-associated phosphoprotein (p18) maps to chromosome bands 1p35-36.1. Genes Chromosomes Cancer 2: 125-129, 1990.
8. Friedrich B, Gronberg H, Landstrom M, Gullberg M, and Bergh A. Differentiation stage specific expression of oncoprotein 18 in human and rat prostatic adenocarcinoma. Prostate 27: 102-109, 1995.
9. Holmfeldt P, Larsson N, Segerman B, Howell B, Morabito J, Cassimeris L, and Gullberg M. The catastrophe-promoting activity of ectopic Op18/stathmin is required for disruption of mitotic spindles but not interphase microtubules. Mol Biol Cell 12: 73-83, 2001.
10. Hughes J, Brown P, and Shankland SJ. Cyclin kinase inhibitor p21CIP1/WAF1 limits interstitial cell proliferation following ureteric obstruction. Am J Physiol Renal Physiol 277: F948-F956, 1999.
11. Humes HD, Lake EW, and Liu S. Renal tubule cell repair following acute renal injury. Miner Electrolyte Metab 21: 353-365, 1995.
12. Iancu C, Mistry SJ, Arkin S, Wallenstein S, and Atweh GF. Effects of stathmin inhibition on the mitotic spindle. J Cell Sci 114: 909-916, 2001.
13. Jaskulski D, deRiel JK, Mercer WE, Calabretta B, and Baserga R. Inhibition of cellular proliferation by antisense oligodeoxynucleotides to PCNA cyclin. Science 240: 1544-1546, 1988.
14. Johnsen JI, Aurelio ON, Kwaja Z, Jorgensen GE, Pellegata NS, Plattner R, Stanbridge EJ, and Cajot JF. p53-Mediated negative regulation of stathmin/Op18 expression is associated with G(2)/M cell-cycle arrest. Int J Cancer 88: 685-691, 2000.
15. Johnson WE, Jones NA, Rowlands DC, Williams A, Guest SS, and Brown G. Down-regulation but not phosphorylation of stathmin is associated with induction of HL60 cell growth arrest and differentiation by physiological agents. FEBS Lett 364: 309-313, 1995.
16. Kelly KJ, Plotkin Z, Vulgamott SL, and Dagher PC. P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor. J Am Soc Nephrol 14: 128-138, 2003.
17. Larsson N, Marklund U, Gradin HM, Brattsand G, and Gullberg M. Control of microtubule dynamics by oncoprotein 18: dissection of the regulatory role of multisite phosphorylation during mitosis. Mol Cell Biol 17: 5530-5539, 1997.
18. Larsson N, Melander H, Marklund U, Osterman O, and Gullberg M. G2/M transition requires multisite phosphorylation of oncoprotein 18 by two distinct protein kinase systems. J Biol Chem 270: 14175-14183, 1995.
19. Lawler S, Gavet O, Rich T, and Sobel A. Stathmin overexpression in 293 cells affects signal transduction and cell growth. FEBS Lett 421: 55-60, 1998.
20. Liedtke W, Leman EE, Fyffe RE, Raine CS, and Schubart UK. Stathmin-deficient mice develop an age-dependent axonopathy of the central and peripheral nervous systems. Am J Pathol 160: 469-480, 2002.
21. Liu YC, Marraccino RL, Keng PC, Bambara RA, Lord EM, Chou WG, and Zain SB. Requirement for proliferating cell nuclear antigen expression during stages of the Chinese hamster ovary cell cycle. Biochemistry 28: 2967-2974, 1989.
22. Lovric J, Dammeier S, Kieser A, Mischak H, and Kolch W. Activated raf induces the hyperphosphorylation of stathmin and the reorganization of the microtubule network. J Biol Chem 273: 22848-22855, 1998.
23. Luo XN, Mookerjee B, Ferrari A, Mistry S, and Atweh GF. Regulation of phosphoprotein p18 in leukemic cells. Cell cycle regulated phosphorylation by p34cdc2 kinase. J Biol Chem 269: 10312-10318, 1994.
24. Marklund U, Brattsand G, Osterman O, Ohlsson PI, and Gullberg M. Multiple signal transduction pathways induce phosphorylation of serines 16, 25, and 38 of oncoprotein 18 in T lymphocytes. J Biol Chem 268: 25671-25680, 1993.
25. Marklund U, Brattsand G, Shingler V, and Gullberg M. Serine 25 of oncoprotein 18 is a major cytosolic target for the mitogen-activated protein kinase. J Biol Chem 268: 15039-15047, 1993.
26. Marklund U, Larsson N, Brattsand G, Osterman O, Chatila TA, and Gullberg M. Serine 16 of oncoprotein 18 is a major cytosolic target for the Ca2+/calmodulin-dependent kinase-Gr. Eur J Biochem 225: 53-60, 1994.
27. Marklund U, Larsson N, Gradin HM, Brattsand G, and Gullberg M. Oncoprotein 18 is a phosphorylation-responsive regulator of microtubule dynamics. EMBO J 15: 5290-5298, 1996.
28. Marklund U, Osterman O, Melander H, Bergh A, and Gullberg M. The phenotype of a "Cdc2 kinase target site-deficient" mutant of oncoprotein 18 reveals a role of this protein in cell cycle control. J Biol Chem 269: 30626-30635, 1994.
29. Megyesi J, Andrade L, Vieira JM Jr, Safirstein RL, and Price PM. Coordination of the cell cycle is an important determinant of the syndrome of acute renal failure. Am J Physiol Renal Physiol 283: F810-F816, 2002.
30. Megyesi J, Andrade L, Vieira JM Jr, Safirstein RL, and Price PM. Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure. Kidney Int 60: 2164-2172, 2001.
31. 2+/calmodulin-dependent kinase IV/Gr-dependent phosphorylation of oncoprotein 18. Mol Cell Biol 17: 3459-3467, 1997.
32. Mistry SJ and Atweh GF. Role of stathmin in the regulation of the mitotic spindle: potential applications in cancer therapy. Mt Sinai J Med 69: 299-304, 2002.
33. Ozon S, Byk T, and Sobel A. SCLIP: a novel SCG10-like protein of the stathmin family expressed in the nervous system. J Neurochem 70: 2386-2396, 1998.
34. Ozon S, Guichet A, Gavet O, Roth S, and Sobel A. Drosophila stathmin: a microtubule-destabilizing factor involved in nervous system formation. Mol Biol Cell 13: 698-710, 2002.
35. Ozon S, Maucuer A, and Sobel A. The stathmin family-molecular and biological characterization of novel mammalian proteins expressed in the nervous system. Eur J Biochem 248: 794-806, 1997.
36. Park SK, Kang MJ, Kim W, and Koh GY. Renal tubule regeneration after ischemic injury is coupled to the up-regulation and activation of cyclins and cyclin dependent kinases. Kidney Int 52: 706-714, 1997.
37. Park SK, Kim W, Lee CH, and Koh GY. Differential changes of CDK activities in glomeruli and tubules during the active DNA synthetic period after ischemic injury. Nephron 86: 306-314, 2000.
38. Prelich G and Stillman B. Coordinated leading and lagging strand synthesis during SV40 DNA replication in vitro requires PCNA. Cell 53: 117-126, 1988.
39. Prelich G, Tan CK, Kostura M, Mathews MB, So AG, Downey KM, and Stillman B. Functional identity of proliferating cell nuclear antigen and a DNA polymerase-delta auxiliary protein. Nature 326: 517-520, 1987.
40. Rowlands DC, Williams A, Jones NA, Guest SS, Reynolds GM, Barber PC, and Brown G. Stathmin expression is a feature of proliferating cells of most, if not all, cell lineages. Lab Invest 72: 100-113, 1995.
41. Schubart UK, Yu J, Amat JA, Wang Z, Hoffmann MK, and Edelmann W. Normal development of mice lacking metablastin (P19), a phosphoprotein implicated in cell cycle regulation. J Biol Chem 271: 14062-14066, 1996.
42. Shankland SJ and Wolf G. Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 278: F515-F529, 2000.
43. Smits VA, Klompmaker R, Vallenius T, Rijksen G, Makela TP, and Medema RH. p21 inhibits Thr161 phosphorylation of Cdc2 to enforce the G2 DNA damage checkpoint. J Biol Chem 275: 30638-30643, 2000.
44. Tzivion G, Shen YH, and Zhu J. 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene 20: 6331-6338, 2001.
45. Witzgall R, Brown D, Schwarz C, and Bonventre JV. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 93: 2175-2188, 1994.
46. Zahedi K, Wang Z, Barone S, Tehrani K, Yokota N, Petrovic S, Rabb H, and Soleimani M. Identification of stathmin as a novel marker of cell proliferation in the recovery phase of acute ischemic renal failure. Am J Physiol Cell Physiol 286: C1203-C1211, 2004.
47. Zweier JL, Duilio C, Kuppusamy P, Santoro G, Elia PP, Tritto I, Cirillo P, Condorelli M, and Chiariello M. A short burst of oxygen radicals at reflow induces sustained release of oxidized glutathione from postischemic hearts. J Biol Chem 268: 18532-18541, 1993.